0.6463USD-0.11%Mkt Cap: 29.02M $P/E: —2d ago
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's a…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap29.02M $
Enterprise Value56.19M $
Revenue (TTM)79.91M $
Gross Profit54.34M $
Net Income (TTM)-38.83M $
Revenue/Share1.509 USD
Last Price0.6463 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees218
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.22
PEG—
EV/EBITDA-1.70
EV/Revenue0.70
P/S0.36
P/B-1.81
EPS (TTM)-0.75
EPS (Forward)-0.52
52W Range
0.501010% of range2.000
52W High2.000 USD
52W Low0.5010 USD
Profitability
Gross Margin67.69%
Oper. Margin-48.12%
EBITDA Margin-41.31%
Profit Margin-48.37%
ROE-615.10%
ROA-47.69%
Growth
Revenue Growth-4.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.22M $
CapEx (TTM)448.00K $
FCF Margin-22.17%
FCF Yield-61.05%
Net Debt27.49M $
Net Debt/EBITDA-0.83
Balance Sheet
Debt/Equity8.90
Current Ratio2.99
Quick Ratio2.20
Book Value/Sh-0.3540 USD
Cash/Share0.6780 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.100 USD
Upside (mean)+224.9%
Target Range1.000 USD – 3.000 USD
$1.000+224.9% to mean$3.000
# Analysts5
Ownership
Shares Out.44.89M
Float21.52M
Insiders8.84%
Institutions65.91%
Short Interest
Short Ratio6.6d
Short % Float1.10%
Short % Out.0.76%
Shares Short341.49K
Short (prev mo.)466.22K
Technical
SMA 500.7689 (-15.9%)
SMA 2000.8898 (-27.4%)
Beta1.36
S&P 52W Chg18.16%
Avg Vol (30d)121.49K
Avg Vol (10d)212.20K
Technical Indicators
RSI (14)39.4
MACD-0.0291
MACD Signal-0.0114
MACD Hist.-0.0176
BB Upper0.9409 USD
BB Middle0.7418 USD
BB Lower0.5427 USD
BB Width53.67%
ATR (14)0.0929 USD
Vol Ratio (20d)0.39x